IMS Releases 2016 Report on Prescription Drug Spending – Net Price Growth 2.8% in 2015

Discussion on Medicare Part B Drug Payment Model Demonstration

http://feeds.feedblitz.com/~/152450368/0/policymed~IMS-Releases-Report-on-Prescr...

Source: Policy and Medicine - May 1, 2016 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs

More News: AstraZeneca | Autoimmune Disease | Cancer | Cancer & Oncology | Cardiology | Copaxone | Crestor | Diabetes | Endocrinology | Environmental Health | Erectile Dysfunction | Filgrastim | Government | Health | Health Management | Health Medicine & Bioethics Commentators | Heart | Heart Disease | Hepatitis | Hepatitis C | Insurers | Liver | Lyrica | Medicare | Men | Neulasta | Neupogen | Pain | Pfizer | Politics | Rare Diseases | Rosuvastatin | Suboxone | Urology & Nephrology | Viagra